$DYN
Dyne Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is DYN up today? It is at $26.30 (+0.50%), and our scanner flagged it 100 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment DYN spikes, and full due diligence on DYN — key stats, earnings, dilution and insider activity. Free.
Get free $DYN alerts the moment volume spikes
Our scanner flagged $DYN 100 times in the last 30 days. Create a free account to track $DYN, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $26.30
- Change today
- +0.50%
- Previous close
- $26.17
- 52-week range
- $10.78 – $27.09
- Market cap
- $4.89B
- Institutional own.
- 99.9%
- Total held
- 100.0%
- Short interest
- 21.5M ▼ -4% vs prior · as of 2026-07-15
- Days to cover
- 10.6d
- Avg daily volume
- 2.4M
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5m
- 0.3x
- 15m
- 0.6x
- 1h
- 0.8x
- 1D
- 0.1x
Get free DYN + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $DYN moving today?
Here is the latest on DYN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for DYN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystDyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business HighlightsReported Dyne entered into an amendment to its non-dilutive senior secured term loan facility with Hercules Capital, Inc. in June 2026, expanding its debt facility to up to $400 million., from the latest SEC filing. Read it →Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $DYN runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- Priced at $20.50/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$DYN Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$DYN Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to DYN
Comparable names in pharmaceutical preparations, closest in size first.
DYN stock FAQ
Why is $DYN moving today?
Here is the latest on DYN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for DYN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the DYN stock price today?
DYN last traded at $26.30, up 0.50% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live DYN alerts?
The DYN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged DYN 100 times in the last 30 days.
What exchange is DYN on?
DYN (Dyne Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $4.89B in the PHARMACEUTICAL PREPARATIONS sector.
Is DYN good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge DYN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.